Page 214 - Pagetit

6. CONCURRENT DISORDERS

Blier P, de Montigny C (1994) Current advances and trends in the treatment of
depression. Trends in Pharmacological Sciences, 15:220–226.
Blier P, de Montigny C, Chaput Y (1990) A role for the serotonin system in the
mechanism of action of antidepressant treatments: preclinical evidence. Journal
of Clinical Psychiatry, 51 Suppl: S14–S20.
Bogerts B (1993) Hippocampus-amygdala volumes and psychopathology in
chronic schizophrenia. Biological Psychiatry, 33:236–246.
Bokstrom K, Balldin J (1992) A rating scale for assessment of alcohol withdrawal
psychopathology (AWIP). Alcoholism: Clinical and Experimental Research,
16:241–249.
Breslau N (1995) Psychiatric comorbidity of smoking and nicotine dependence.
Behavior Genetics, 25:95–101.
Breslau N, Kilbey MM, Andreski P (1993) Nicotine dependence and major
depression: new evidence from a prospective investigation. Archives of General
Psychiatry, 50:31–35.
Breslau N et al. (1998) Major depression and stages of smoking: a longitudinal
investigation. Archives of General Psychiatry, 55:161–166.
Buckley P et al. (1994) Substance abuse among patients with treatment-resistant
schizophrenia: characteristics and implications for clozapine therapy. American
Journal of Psychiatry, 151:385–389.
Caldecott-Hazard S, Schneider LS (1992) Clinical and biochemical aspects of
depressive disorders. III. Treatment and controversies. Synapse, 10:141–168.
Caldecott-Hazard S et al. (1991) Clinical and biochemical aspects of depressive
disorders. II. Transmitter/receptor theories. Synapse, 9:251–301.
Carlsson A (1977) Does dopamine play a role in schizophrenia? Psychological
Medicine, 7:583–597.
Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, Di
Mascio A, Killian KF, eds. Psychopharmacology: a generation in progress. New York,
NY, Raven Press:1057–1070.
Carol G et al. (2001) A preliminary investigation of cocaine craving among persons
with and without schizophrenia. Psychiatry Services, 52:1029–1031.
Cesarec Z, Nyman AK (1985) Differential response to amphetamine in
schizophrenia. Acta Psychiatrica Scandinavica, 71:523–538.
Chabrol H, Armitage J (2002) Substance use and the development of antisocial
personality in depressed adolescents. Archives of General Psychiatry, 59:665.
Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance
abuse comorbidity in schizophrenia. Biological Psychiatry, 50:71–83.
Chaput Y, de Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications
of the serotonin system by long-term administration of antidepressant treatments:
an in vivo electrophysiologic study in the rat. Neuropsychopharmacology, 5:219–
229.
Claghorn J et al. (1987) The risks and benefits of clozapine versus
chloropromazine. Journal of Clinical Psychopharmacology, 7:377–384.

193

Chapter_6 193 19.1.2004, 11:49